Summary
In a significant market movement during January 2025, Oxcan was the subject of a vc funding. The transaction achieved a gross valuation of £8,934,618. Leading the round was Civilization Ventures, DigitalDx Ventures, OKG Capital, Aurelium Ventures, We Venture Capital, Cross-Border Impact Ventures, Eka Ventures, Macmillan Cancer Support.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Civilization Ventures
Lead Investor / Acquirer
DigitalDx Ventures
Lead Investor / Acquirer
OKG Capital
Lead Investor / Acquirer
Aurelium Ventures
Lead Investor / Acquirer
We Venture Capital
Lead Investor / Acquirer
Cross-Border Impact Ventures
Lead Investor / Acquirer
Eka Ventures
Lead Investor / Acquirer
Macmillan Cancer Support
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in